Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:plasma plasminogen activator inhibitor 1 level
go back to main search page
Accession:CMO:0003695 term browser browse the term
Definition:Measurement of the amount of plasminogen activator inhibitor 1 (PAI-1) in a specified sample of plasma, the fibrinogen-containing fluid portion of the blood in which the particulate components are suspended. PAI-1 is a serine protease inhibitor protein that functions as the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis (the physiological breakdown of blood clots).
Synonyms:exact_synonym: plasma Serpine1 level;   plasma PAI1 level;   plasma serpin family E member 1 level
 xref: PMID:23799078



show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "plasma plasminogen activator inhibitor 1 level" (CMO:0003695)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    blood measurement 443
      blood chemistry measurement 426
        blood protein measurement 188
          blood plasminogen activator inhibitor 1 level 0
            plasma plasminogen activator inhibitor 1 level 0
paths to the root